Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Toxic and adverse reactions encountered with new beta-lactam antibiotics.

Literature DB >> 6586251

Toxic and adverse reactions encountered with new beta-lactam antibiotics.

M F Parry.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1984 PMID： 6586251 PMCID： PMC1911778

Source DB: PubMed Journal: Bull N Y Acad Med ISSN： 0028-7091

× No keyword cloud information.

35 in total

1. The safety and tolerance of mezlocillin.

Authors: M F Parry; H C Neu
Journal: J Antimicrob Chemother Date: 1982-01 Impact factor: 5.790

2. Coagulopathy associated with the use of moxalactam.

Authors: R L Pakter; T R Russell; C H Mielke; D West
Journal: JAMA Date: 1982-09-03 Impact factor: 56.272

3. Bleeding in patients with infections. Are antibiotics helping or hurting?

Authors: R Hochman; J Clark; A Rolla; S Thomas; A Kaldany; J A D'Elia
Journal: Arch Intern Med Date: 1982-08

4. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

Authors: V L Yu
Journal: Ann Intern Med Date: 1981-06 Impact factor: 25.391

5. Cefoxitin falsely elevates creatinine levels.

Authors: A J Saah; T R Koch; G L Drusano
Journal: JAMA Date: 1982-01-08 Impact factor: 56.272

6. Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.

Authors: C J Schleupner; J C Engle
Journal: Antimicrob Agents Chemother Date: 1982-02 Impact factor: 5.191

7. Clinical efficacy of cefotaxime in serious infections.

Authors: P H Karakusis; J M Feczko; L J Goodman; D M Hanlon; A A Harris; S Levin; G M Trenholme
Journal: Antimicrob Agents Chemother Date: 1982-01 Impact factor: 5.191

Review 8. Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.

Authors: R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal: Drugs Date: 1981-12 Impact factor: 9.546

Toxic and adverse reactions encountered with new beta-lactam antibiotics.

1. The safety and tolerance of mezlocillin.

2. Coagulopathy associated with the use of moxalactam.

3. Bleeding in patients with infections. Are antibiotics helping or hurting?

4. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

5. Cefoxitin falsely elevates creatinine levels.

6. Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.

7. Clinical efficacy of cefotaxime in serious infections.

Review 8. Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.

9. Moxalactam therapy for bacterial infections.

10. Effects of sodium piperacillin on platelet function in normal volunteers.

Review 1. Clinical features, pathogenesis and management of drug-induced seizures.

Review 2. Efficacy and safety of cefotaxime in the management of pediatric infections.

Review 3. Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Review 4. A review of the adverse events profile of cefpirome.